Cobicistat as a Pharmacoenhancer in Pregnancy and Postpartum: Progress to Date and Next Steps

J Clin Pharmacol. 2019 Jun;59(6):779-783. doi: 10.1002/jcph.1397. Epub 2019 Mar 1.

Authors

Ahizechukwu C Eke^{1

2}, Mark H Mirochnick³

Affiliations

¹ Division of Maternal Fetal Medicine & Clinical Pharmacology, Department of Gynecology & Obstetrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
² Doctoral Training Program (PhD), Graduate Training Program in Clinical Investigation (GTPCI), Johns Hopkins University School of Public Health, Baltimore, MD, USA.
³ Division of Neonatology, Department of Pediatrics, Boston University School of Medicine, Boston, MA, USA.

No abstract available

Keywords: cobicistat; pharmacoenhancers; postpartum; pregnancy; ritonavir.

Publication types

Letter

MeSH terms

Anti-HIV Agents / administration & dosage
Anti-HIV Agents / therapeutic use*
Cobicistat / administration & dosage
Cobicistat / therapeutic use*
Female
Humans
Postpartum Period
Pregnancy
Ritonavir / therapeutic use

Substances

Anti-HIV Agents
Cobicistat
Ritonavir

Grants and funding

T32 GM066691/GM/NIGMS NIH HHS/United States